These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32773406)

  • 1. Krabbe disease successfully treated via monotherapy of intrathecal gene therapy.
    Bradbury AM; Bagel JH; Nguyen D; Lykken EA; Pesayco Salvador J; Jiang X; Swain GP; Assenmacher CA; Hendricks IJ; Miyadera K; Hess RS; Ostrager A; ODonnell P; Sands MS; Ory DS; Shelton GD; Bongarzone ER; Gray SJ; Vite CH
    J Clin Invest; 2020 Sep; 130(9):4906-4920. PubMed ID: 32773406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy.
    Bradbury AM; Bagel J; Swain G; Miyadera K; Pesayco JP; Assenmacher CA; Brisson B; Hendricks I; Wang XH; Herbst Z; Pyne N; Odonnell P; Shelton GD; Gelb M; Hackett N; Szabolcs P; Vite CH; Escolar M
    Mol Ther; 2024 Jan; 32(1):44-58. PubMed ID: 37952085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease).
    Bradbury AM; Rafi MA; Bagel JH; Brisson BK; Marshall MS; Pesayco Salvador J; Jiang X; Swain GP; Prociuk ML; ODonnell PA; Fitzgerald C; Ory DS; Bongarzone ER; Shelton GD; Wenger DA; Vite CH
    Hum Gene Ther; 2018 Jul; 29(7):785-801. PubMed ID: 29316812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
    Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
    J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of a Krabbe Disease Gene Therapy.
    Hordeaux J; Jeffrey BA; Jian J; Choudhury GR; Michalson K; Mitchell TW; Buza EL; Chichester J; Dyer C; Bagel J; Vite CH; Bradbury AM; Wilson JM
    Hum Gene Ther; 2022 May; 33(9-10):499-517. PubMed ID: 35333110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.
    Rafi MA; Rao HZ; Luzi P; Curtis MT; Wenger DA
    Mol Ther; 2012 Nov; 20(11):2031-42. PubMed ID: 22850681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.
    Rafi MA; Rao HZ; Luzi P; Wenger DA
    Mol Ther; 2015 Nov; 23(11):1681-1690. PubMed ID: 26329589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
    Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
    Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.
    Pan X; Sands SA; Yue Y; Zhang K; LeVine SM; Duan D
    Hum Gene Ther; 2019 Sep; 30(9):1039-1051. PubMed ID: 31184217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
    Bradbury AM; Bagel JH; Jiang X; Swain GP; Prociuk ML; Fitzgerald CA; O'Donnell PA; Braund KG; Ory DS; Vite CH
    J Neurosci Res; 2016 Nov; 94(11):1007-17. PubMed ID: 27638585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.
    Feltri ML; Weinstock NI; Favret J; Dhimal N; Wrabetz L; Shin D
    Glia; 2021 Oct; 69(10):2309-2331. PubMed ID: 33851745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine, canine and non-human primate models of Krabbe disease.
    Wenger DA
    Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.
    Heller GJ; Marshall MS; Issa Y; Marshall JN; Nguyen D; Rue E; Pathmasiri KC; Domowicz MS; van Breemen RB; Tai LM; Cologna SM; Crocker SJ; Givogri MI; Sands MS; Bongarzone ER
    Mol Ther; 2021 May; 29(5):1883-1902. PubMed ID: 33508430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Pathogenesis and Treatment of Krabbe Disease.
    Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krabbe disease: New hope for an old disease.
    Bradbury AM; Bongarzone ER; Sands MS
    Neurosci Lett; 2021 May; 752():135841. PubMed ID: 33766733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.